NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.26
-0.59 (-1.65%)
At close: Dec 5, 2025, 4:00 PM EST
35.00
-0.26 (-0.74%)
After-hours: Dec 5, 2025, 6:50 PM EST
NAMS Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for NAMS stock have an average target of 45.8, with a low estimate of 37 and a high estimate of 52. The average target predicts an increase of 29.89% from the current stock price of 35.26.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for NAMS stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Buy | 4 | 5 | 5 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $30 → $37 | Hold | Maintains | $30 → $37 | +4.93% | Dec 2, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $39 → $44 | Buy | Maintains | $39 → $44 | +24.79% | Nov 6, 2025 |
| Needham | Needham | Strong Buy Maintains $40 → $46 | Strong Buy | Maintains | $40 → $46 | +30.46% | Nov 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $52 | Strong Buy | Initiates | $52 | +47.48% | Oct 20, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $42 → $50 | Strong Buy | Maintains | $42 → $50 | +41.80% | Oct 17, 2025 |
Financial Forecast
Revenue This Year
30.09M
from 45.56M
Decreased by -33.95%
Revenue Next Year
26.63M
from 30.09M
Decreased by -11.51%
EPS This Year
-1.49
from -2.56
EPS Next Year
-1.84
from -1.49
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 57.5M | 81.9M | ||||
| Avg | 30.1M | 26.6M | ||||
| Low | 22.0M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 26.3% | 172.1% | ||||
| Avg | -34.0% | -11.5% | ||||
| Low | -51.7% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.98 | -1.30 | ||||
| Avg | -1.49 | -1.84 | ||||
| Low | -1.70 | -2.85 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.